DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Ethylphenidate
Ethylphenidate
Free PDF Download
Seven Fatalities Associated with Ethylphenidate
(19) United States (12) Patent Application Publication (10) Pub
Carbon-I I-D-Threo-Methylphenidate Binding to Dopamine Transporter in Baboon Brain
Advisory Council on the Misuse of Drugs
Methylphenidate-Based
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismss
Peer-Reviewed Abstract Presented at the 2015
World of Cognitive Enhancers
Neurochemical Studies of Attention-Deficit/ Hyperactivity Disorder Medications in the Striatum and Nucleus Accumbens of the Fischer 344 Rat
Unravelling the Effects of Methylphenidate on The
World Report 2017
(12) Patent Application Publication (10) Pub. No.: US 2010/0166889 A1 Sanfilippo (43) Pub
Pharmacokinetic and Pharmacodynamic Drug Interactions Methylphenidate, Amphetamine, Or Atomoxetine in ADHD
Controlled Substances List (Adopted by Alabama State Board of Health on January 20, 2021, Effective January 20, 2021)
Isopropylphenidate: an Ester Homolog of Methylphenidate with Sustained and Selective Dopaminergic Activity and Reduced Drug Interaction Liability
Ethylphenidate: an Analytical Profile
Immediate Action Test Updates
Top View
Dexmethylphenidate Hydrochloride Tablets)
Absorption Differences Between Immediate-Release Dexmethylphenidate and Dl-Methylphenidate
Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS)
Pharmacological Profile of Methylphenidate-Based Designer Drugs
Substance Abuse in the Workplaces of Our Bodies and Mind
2020 Controlled Substance List
WHO Expert Committee on Drug Dependence (ECDD)
In Vitro Neurochemical Assessment of Methylphenidate and Its ``Legal
Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
Characterization of Influx Transporters in the Blood-Brain Barrier: Implications for Drug Delivery
Ethylphenidate (EPH) Critical Review Report Agenda Item 4.7
Temporary Class Drug Order (TCDO)
Ethylphenidate: from Biomarker to Designer Drug John S
Current P SYCHIATRY Visit the All-New Currentpsychiatry.Com
(12) Patent Application Publication (10) Pub. No.: US 2012/0245201 A1 Markowitz Et Al
Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances NEPTUNE
Metabolomics of Methylphenidate and Ethylphenidate: Implications in Pharmacological and Toxicological Effects
Comparative Efficacy, Acceptability, and Tolerability Of